The Japanese Society for Orthomolecular Medicine (JSOM) was formalized in 2002, and had been providing information on orthomolecular treatments mainly for psychiatric diseases. In 2017, the JSOM was reestablished as an official institute in order to further advance orthomolecular medicine in Japan, and to strengthen the network of professionals in orthomolecular medicine for the Annual International Orthomolecular Medicine Today Conference in 2018 in Tokyo.

The main objectives of the Japanese Society for Orthomolecular Medicine are:

1) To enlighten and educate healthcare professionals in Japan with orthomolecular medicine;
2) To provide accurate information for the public and industries in order to raise awareness and develop the needs for orthomolecular medicine;
3) To establish a network of clinicians, academics, and other related professionals in orthomolecular medicine in Japan and the world.

JSOM Executive Board Members:

Atsuo Yanagisawa, MD, PhD
President, Japanese Society for Orthomolecular Medicine
Past President, International Society for Orthomolecular Medicine

Tomomi Himeno, MD, PhD
Chairman of Himeno Tomomi Clinic

Naoko Ideguchi, PhD
Professor, Faculty of Pharmaceutical Sciences at Teikyo Heisei University

Hiroshi Iizuka, MD, PhD
Director of Medical Stress Care Iizuka Clinic

Toshiyuki Kaneko, MD
Representative Director of NPO Society for Orthomolecular Nutrition Medicine

Tsuyoshi Kitahara
Representative, Detox Inc.

Michiko Miyagawa, MD, PhD
Professor of Hosei University

Toru Mizoguchi, MD
Director of Mizoguchi Clinic

Osamu Mizukami, MD, PhD
Director of Health Promotion Clinic

Yoshimu Tanaka, MD, PhD
Chairman of Tanaka Clinic

Kazunaga Yazawa, PhD
Professor, Waseda University